PTC Therapeutics director Michael Schmertzler sells $1.8m in shares

PTC Therapeutics director Michael Schmertzler sold shares worth $1.8 million.

AI CATALYST SCORE40 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

Diagnosed At	Ticker	AI Score	Tier
2026-08-29 04:28:52	PTCT	40	Row	View Report →
2026-08-22 08:21:56	PTCT	35	Row	View Report →
2026-07-16 21:28:30	PTCT	65	Mid	View Report →

PTCT Analysis History (Last 30 Days)